Lv3
360 积分 2025-03-04 加入
Prognostic implications of uncommon EGFR exon 19 deletion-insertion mutations in non-small cell lung cancer treated with third-generation EGFR-TKIs
26天前
已完结
Efficacy of EGFR-Tyrosine Kinase Inhibitors for advanced non-small cell lung cancer patients harboring rare EGFR mutations of exon 18 E709X
1个月前
已完结
Treatment-Related Toxicity in Patients with Early Stage Non–Small Cell Lung Cancer and Co-Existing Interstitial Lung Disease: A Systematic Review
2个月前
已完结
Genomic profiles of lung cancer associated with idiopathic pulmonary fibrosis
2个月前
已完结
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
2个月前
已完结
Combined intrathecal therapy via Ommaya reservoir and whole-brain radiotherapy improves survival in EGFR-mutant NSCLC patients with leptomeningeal metastases: a real-world cohort study
3个月前
已完结
Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR- mutated non-small cell lung cancer: systematic review and network meta-analysis
4个月前
已完结
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
5个月前
已完结
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
6个月前
已完结
Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer
6个月前
已完结
皖公网安备34019202002308
